Recombinant multi-species eIF4G2/DAP5/EIF4G2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine eIF4G2/DAP5/EIF4G2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. The protein encoded by this gene shares similarity with the C-terminal region of eIF4G that contains the binding sites for eIF4A and eIF3; eIF4G, in addition, contains a binding site for eIF4E at the N-terminus. Unlike eIF4G, which supports cap-dependent and independent translation, this gene product functions as a general repressor of translation by forming translationally inactive complexes. In vitro and in vivo studies indicate that translation of this mRNA initiates exclusively at a non-AUG (GUG) codon. Alternatively spliced transcript variants encoding different isoforms of this gene have been described. [provided by RefSeq, Jul 2008]
The Alternative Names of target: AAG1,DAP-5,DAP5,Death-associated protein 5 (DAP-5),E130105L11Rik,EIF4G2,Eif4g2,Eukaryotic translation initiation factor 4 gamma 2,NAT1,Nat1,Natm1,P97,eIF-4-gamma 2,eIF-4G 2,eIF4G 2,eIF4G2,p97

Target products collectionGo to eIF4G2/DAP5/EIF4G2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6317-Ag-1/ GM-Tg-hg-IP6317-Ag-2 Human eIF4G2/DAP5/EIF4G2 protein Human
GM-Tg-rg-IP6317-Ag-1/ GM-Tg-rg-IP6317-Ag-2 Rat eIF4G2/DAP5/EIF4G2 protein Rat
GM-Tg-mg-IP6317-Ag-1/ GM-Tg-mg-IP6317-Ag-2 Mouse eIF4G2/DAP5/EIF4G2 protein Mouse
GM-Tg-cynog-IP6317-Ag-1/ GM-Tg-cynog-IP6317-Ag-2 Cynomolgus/Rhesus macaque eIF4G2/DAP5/EIF4G2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6317-Ag-1/ GM-Tg-felg-IP6317-Ag-2 Feline eIF4G2/DAP5/EIF4G2 protein Feline
GM-Tg-cang-IP6317-Ag-1/ GM-Tg-cang-IP6317-Ag-2 Canine eIF4G2/DAP5/EIF4G2 protein Canine
GM-Tg-bovg-IP6317-Ag-1/ GM-Tg-bovg-IP6317-Ag-2 Bovine eIF4G2/DAP5/EIF4G2 protein Bovine
GM-Tg-equg-IP6317-Ag-1/ GM-Tg-equg-IP6317-Ag-2 Equine eIF4G2/DAP5/EIF4G2 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6317-Ag-1/ GM-Tg-hg-IP6317-Ag-2; GM-Tg-rg-IP6317-Ag-1/ GM-Tg-rg-IP6317-Ag-2;
GM-Tg-mg-IP6317-Ag-1/ GM-Tg-mg-IP6317-Ag-2; GM-Tg-cynog-IP6317-Ag-1/ GM-Tg-cynog-IP6317-Ag-2;
GM-Tg-felg-IP6317-Ag-1/ GM-Tg-felg-IP6317-Ag-2; GM-Tg-cang-IP6317-Ag-1/ GM-Tg-cang-IP6317-Ag-2;
GM-Tg-bovg-IP6317-Ag-1/ GM-Tg-bovg-IP6317-Ag-2; GM-Tg-equg-IP6317-Ag-1/ GM-Tg-equg-IP6317-Ag-2
Products Name eIF4G2/DAP5/EIF4G2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name eIF4G2/DAP5/EIF4G2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine eIF4G2/DAP5/EIF4G2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.